TABLE 1.
Study reference no. | Study design | Population | Intervention/comparator | Outcome | AOR (95% CI) | AHR (95% CI) |
---|---|---|---|---|---|---|
(63) | Secondary analysis of NHANES 2003–2006 survey data | Adult, civilian, noninstitutionalized, residential USA | ≥3 vs. <2 servings/wk yoghurt or probiotic supplement | Prevalent proteinuric kidney disease | 0.76 (0.61, 0.94) | — |
(64) | Secondary analysis of NHANES 1999–2014 | Adult, civilian, noninstitutionalized, residential USA | Yogurt and/or probiotic supplementation vs. neither | Obesity | 0.83 (0.76, 0.92) | — |
(65) | Secondary analysis of NHANES 1999–2010 | Adult (≥20 y old), civilian, noninstitutionalized, residential USA | Top vs. bottom 4th of yogurt consumption | Mortality | — | 0.89 (0.83, 0.94)* |
*When additional covariates for body mass index, hypertension, and diabetes were included, the beneficial effect of yogurt was slightly attenuated to AHR=0.93 (0.85, 1.01)